O'Shaughnessy, J <br/><br/>
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2016 
 - 106-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdv487  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abiraterone Acetate--administration & dosage<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androstadienes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Postmenopause<br/>Proportional Hazards Models<br/>Receptors, Estrogen--metabolism<br/>Treatment Outcome